Answers are grounded in this paper and cite their sources.
Randomized controlled trial shows comparable MTPM between cemented and uncemented total knee arthroplasty components, suggesting acceptable early migration values.
Commentary In their randomized controlled trial (RCT), Altun et al. showed promising results for a specific knee implant design. The study evaluated maximal total point motion (MTPM) of cemented and uncemented components using radiostereometric analysis (RSA). As early implant migration is a known predictor of aseptic loosening, this study presents several important findings for clinicians and patients regarding implant fixation and potential long-term performance. When new total knee arthroplasty (TKA) designs are introduced, it is vital to evaluate them in detail to identify any design flaws and ensure patient safety. Not all TKAs perform equally well. In their analysis of the Australian Orthopaedic Association National Joint Replacement Registry, Lewis et al. evaluated updated TKA designs and found that, although many showed improved survivorship, some showed no difference, and others had a higher revision rate compared with older designs1. Thus, as surgeons and clinicians, we need to carefully adopt new prostheses. Early studies using RSA are an excellent way to evaluate new TKA designs. RSA detects small amounts of implant migration, and, importantly, early detection has been correlated with aseptic loosening and component failure. Pijls et al. performed a meta-analysis of studies evaluating >20,000 TKAs and found that, for every 1-mm increase in implant migration, there was an 8% increase in revision risk2. Pijls et al. concluded that tibial component migration up to 0.5 mm was acceptable during the first year, although migration of >1.6 mm was unacceptable. Values in between were classified as "at risk" for requiring revision. The present study found that the mean MTPM migration at 12 months was 0.72 mm for cemented tibial components and 0.79 mm for uncemented tibial components. Subsequently, minimal migration (<0.2 mm) from years 1 to 2 was observed, indicating acceptable migration values and a low risk of aseptic loosening. Femoral components are also important to evaluate in the context of new implant designs. This study found greater migration for uncemented components, with MTPM values of 0.51 mm for cemented components and 0.83 mm for uncemented components at 24 months. This difference was significant and was considered clinically acceptable based on previous literature demonstrating a mean MTPM of 0.87 mm for uncemented components at 24 months. Furthermore, migration from 12 to 24 months was minimal: 0.02 mm in the cemented component group and 0.04 mm in the uncemented component group for the specific prosthesis evaluated. These findings demonstrate appropriate stability, aligned with the results of the study by Henricson et al., who performed an RCT of cemented and uncemented femoral components and found that annual migration of 0.1 mm was associated with good long-term performance3. Overall, Altun et al. suggest that the evaluated TKA design exhibits acceptable migration values, indicating the potential for long-term success. Importantly, long-term clinical studies will be important to evaluate the survivorship of this specific implant. The uncemented femoral components showed greater migration than the cemented femoral components, but their migratory values were within an acceptable range and only increased from 0.79 mm at 12 months to 0.83 mm at 24 months. Future studies not only should evaluate long-term outcomes but also should evaluate for any differences in survivorship of cemented components compared with uncemented components.
No takes yet. Share an insight, caveat, or question.
Hernandez et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: